Elkfork Partners’s Charles River Laboratories CRL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q3 | $932K | Sell |
7,040
-4,422
| -39% | -$585K | 0.02% | 403 |
|
|
2019
Q2 | $1.63M | Buy |
11,462
+2,530
| +28% | +$359K | 0.04% | 303 |
|
|
2019
Q1 | $1.3M | Buy |
8,932
+2,684
| +43% | +$390K | 0.03% | 339 |
|
|
2018
Q4 | $707K | Sell |
6,248
-1,496
| -19% | -$169K | 0.02% | 427 |
|
|
2018
Q3 | $1.04M | Buy |
7,744
+1,056
| +16% | +$142K | 0.02% | 372 |
|
|
2018
Q2 | $751K | Sell |
6,688
-3,476
| -34% | -$390K | 0.02% | 418 |
|
|
2018
Q1 | $1.09M | Sell |
10,164
-66
| -0.6% | -$7.05K | 0.03% | 316 |
|
|
2017
Q4 | $1.12M | Buy |
10,230
+5,874
| +135% | +$643K | 0.03% | 336 |
|
|
2017
Q3 | $471K | Buy |
4,356
+660
| +18% | +$71.4K | 0.01% | 503 |
|
|
2017
Q2 | $374K | Buy |
3,696
+440
| +14% | +$44.5K | 0.01% | 555 |
|
|
2017
Q1 | $293K | Sell |
3,256
-132
| -4% | -$11.9K | 0.01% | 536 |
|
|
2016
Q4 | $258K | Buy |
+3,388
| New | +$258K | 0.01% | 527 |
|